UPDF AI

Safety of fluoroquinolones

José Barberán,Alicia de la Cuerda,4 Authors,Lourdes Cristina Barberán

2023 · DOI: 10.37201/req/143.2023
Revista Espanola de Quimioterapia · 20 Citations

TLDR

The main potentially threatening AEs of fluoroquinolones are reviewed, the alarms issued by regulatory agencies and therapeutic alternatives are reviewed.

Abstract

Fluoroquinolones (FQs) are one of the most commonly prescribed classes of antibiotics. Although they were initially well tolerated in randomized clinical trials, subsequent epidemiological studies have reported an increased risk of threatening, severe, long-lasting, disabling and irreversible adverse effects (AEs), related to neurotoxicity and collagen degradation, such as tendonitis, Achilles tendon rupture, aortic aneurysm, and retinal detachment. This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.